Immune & Anti-Inflammatory

Thymosin Alpha-1

Tα1 · Zadaxin (branded)

An immune-modulating thymic peptide that enhances T-cell function, used in hepatitis and certain cancers.

Overview & Mechanism

Upregulates T-cell maturation and dendritic cell function, stimulates Toll-like receptors, and promotes a Th1 immune response; used as an immunomodulator in chronic infections and cancer.

Research Dosage

Dose

1.6 mg per dose

Route

Subcutaneous injection

Frequency

Twice weekly

Cycle

Per protocol (often 6–12 months)

Reconstitution & Storage

Reconstitution

Reconstitute per vial with provided diluent or bacteriostatic water immediately before use.

Storage

Lyophilized: refrigerate 2–8 °C. Reconstituted: use promptly per manufacturer.

Safety & Side Effects

Generally well tolerated; mild injection-site reactions. Approved in some countries for hepatitis B/C.

Studies

Thymosin alpha-1 in chronic hepatitis B

Thymosin alpha-1 improved virological response in chronic hepatitis B patients with minimal adverse effects.

Read study

References

Research Use Only

This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.